Open AccessCost-effectiveness of anti-oxidant vitamins plus zinc treatment to prevent the progression of intermediate age-related macular degeneration. A Singapore perspective
Author(s) -
Nakul Saxena,
Pradeep Paul George,
Bee Hoon Heng,
Tock Han Lim,
Shao Yong
Publication year - 2015
Publication title -
indian journal of ophthalmology/indian journal of ophthalmology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.542
H-Index - 51
eISSN - 1998-3689
pISSN - 0301-4738
DOI - 10.4103/0301-4738.158533
Subject(s) - medicine , macular degeneration , ranibizumab , placebo , cost effectiveness , aflibercept , regimen , surgery , bevacizumab , ophthalmology , chemotherapy , risk analysis (engineering) , alternative medicine , pathology
To determine if providing high dose anti-oxidant vitamins and zinc treatment age-related eye disease study (AREDS formulation) to patients with intermediate age-related macular degeneration (AMD) aged 40-79 years from Singapore is cost-effective in preventing progression to wet AMD.